Arben Ventures is a pre-seed and seed-stage venture capital firm founded in 2022 by Stanford researchers Ariel Ganz and Ben Rolnik. Based in Palo Alto, California, the firm invests in early-stage deep tech health startups focused on precision medicine, longevity, and related domains.
